“Alzheimer’s Cure Approved by FDA – Only One Pill Needed!”
Slide: 2
“Wow, I should share this!” -- Texts a friend
Slide: 3
“Are you sure it’s real? We should use facts checking tools, try to find the original source and verify and check other sources just to make sure.”
Skepticism ensues....
Slide: 4
Searches for information on the FDA’s website, discovering that the new Alzheimer’s treatment, Lecanemab, is not a cure and has limitations.
FDA
Slide: 5
Let's consult the Mayo Clinic . They found that Lecanemab slows symptoms in early cases but has severe risks, including brain swelling.
Slide: 6
“Imagine if social media flagged questionable health news and provided a ‘Read More’ option to check reliable sources.”
Maybe platforms could highlight credible sources when using information from them .
Slide: 7
Another source shows the drug costs $26,500 annually. That’s not affordable for everyone, jeepers!
Slide: 8
So basically, Lecanemab helps some early-stage patients but isn’t a cure, comes with risks, and is expensive.
Slide: 9
“To be a responsible digital citizen, always verify health claims and question headlines.”
Slide: 10
Sources:Alzheimer's Association. “Donanemab for Treatment of Early Alzheimer’s Disease — News Pending FDA Review.” Alzheimer’s Disease and Dementia, 2023, www.alz.org/alzheimers-dementia/treatments/donanemab. Canadian Teachers’ Federation. (2021, February 22). Break the fake [Video]. YouTube. https://www.youtube.com/watch?v=qHeNabULAE0 Salam, Erum. “FDA Approves Breakthrough Alzheimer’s Drug Lecanemab.” The Guardian, 6 Jan. 2023, www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab.Stiepan, DeeDee. “Alzheimer’s Drug Lecanemab Granted Full Approval by FDA, Mayo Clinic Expert Weighs In.” Mayo Clinic News Network, 6 July 2023, newsnetwork.mayoclinic.org/discussion/alzheimers-drug-lecanemab-granted-full-approval-by-fda-mayo-clinic-expert-weighs-in/.
Over 30 Million Storyboards Created
No Downloads, No Credit Card, and No Login Needed to Try!